Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131939) titled 'Impact of Angiotensin II Receptor Blockers (ARBs) on Survival Outcomes in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors: A Multicenter Real-World Retrospective Cohort Study' on Sept. 8.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Wuxi people's Hospital
Condition:
Non-Small Cell Lung Cancer Patients
hypertension
Intervention:
Non-ARB group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-01
Target Sample Size: Non-ARB group:150;ARB group:100;
Countries of Recruitment:
China
To know more, visit https:/...